Welcome Address from Silke Gillessen and Aurelius Omlin at the Advanced Prostate Cancer Consensus Conference

The co-founders of the 2017 Advanced Prostate Cancer Consensus Conference (APCCC), Silke Gillessen and Aurelius Omlin, discuss with Neal Shore different learnings from the 2015 APCCC and how it prepared them for the 2017 meeting.  In addition, discussion on the number of countries that are represented and different types of specialists that attended the conference this year.  The concept of the modified delphi system is an important factor to the success of the meeting and it has created a high quality responses for panel and subsequent publication is so impactful.  Continue to listen for other elements that contributed to the APCCC's success.

Biographies: 
Silke Gillessen, MD, is a senior consultant in the Medical Oncology-Hematology Department at the Kantonsspital St. Gallen. Silke Gillessen has an excellent reputation in the field of urogenital tumors and due to her specialist knowledge, she is a member of numerous oncology and expert boards. She has numerous research publications and since 1995, she is engaged in collaboration and leadership (as sub-investigator or principle investigator) in multiple clinical trials (Phase I-III) including first-in-man trials.  Silke Gillessen graduated from the Medical School of the University in Basel, Switzerland. She also worked at several hospitals in Switzerland, at Hoffmann-La Roche Inc., Nutley NJ, USA, and at the Dana-Farber Cancer Institute, Boston MA, USA.

Aurelius Omlin, MD, is a professor at the Kantonsspital St. Gallen, Medical Oncology Consultant Department of Oncology/Haematology and Cantonal Hospital St.Gallen (Prof. Th. Cerny) and a 2013 ASCO Merit Award and a member of SAKK (Schweizerische Arbeitsgruppe für Klinische Krebsforschung), ESMO (European Society of Medical Oncology), ASCO (American Society of Clinical Oncology) and FMH (Swiss Medical Association). 

Neal Shore, MD 

Access to all Advanced Prostate Cancer Consensus Conference Video Coverage

Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer